Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3205K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Asagiri, M. Articles by Takayanagi, H. Search for Related Content PubMed PubMed Citation Articles by Asagiri, M. Articles by Takayanagi, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Related Collections Related Article Social Bookmarking                      What's this?

¹ Department of Cell Signaling, Graduate School
² Department of Medicine and Rheumatology, Graduate School
³ Department of Cellular Physiological Chemistry, Graduate School
⁴ Center of Excellence Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Tokyo Medical and Dental University, Tokyo 113-8549, Japan
⁵ Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan
⁶ Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan
⁷ Laboratory of Recombinant Animals, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan
⁸ Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan
⁹ Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga City, Saga 849-8501, Japan
¹⁰ Research Institute of Molecular Pathology, A-1030 Vienna, Austria
¹¹ Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario M5G 2M9, Canada
¹² Department of Medical Biophysics, Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
¹³ Department of Molecular Pathology, Institute of Pathology, University of Wüerzburg, D-97080 Wüerzburg, Germany

CORRESPONDENCE Hiroshi Takayanagi: taka.csi{at}tmd.ac.jp

NFATc1 and NFATc2 are functionally redundant in the immune system, but it was suggested that NFATc1 is required exclusively for differentiation of osteoclasts in the skeletal system. Here we provide genetic evidence that NFATc1 is essential for osteoclast differentiation in vivo by adoptive transfer of NFATc1^–/– hematopoietic stem cells to osteoclast-deficient Fos^–/– mice, and by Fos^–/– blastocyst complementation, thus avoiding the embryonic lethality of NFATc1^–/– mice. However, in vitro osteoclastogenesis in NFATc1-deficient cells was rescued by ectopic expression of NFATc2. The discrepancy between the in vivo essential role of NFATc1 and the in vitro effect of NFATc2 was attributed to selective autoregulation of the NFATc1 gene by NFAT through its promoter region. This suggested that an epigenetic mechanism contributes to the essential function of NFATc1 in cell lineage commitment. Thus, this study establishes that NFATc1 represents a potential therapeutic target for bone disease and reveals a mechanism that underlies the essential role of NFATc1 in bone homeostasis.

Abbreviations used: AP, activator protein; BMM, bone marrow monocyte/macrophage precursor cell; CBP, CREB-binding protein; ChIP, chromatin immunoprecipitation; ES, embryonic stem; FLC, fetal liver cell; MeCP2, methyl-CpG binding protein 2; RANKL, receptor activator of NF-B ligand.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

NFATc1 self-promotes to build bone

Heather L. Van Epps
J. Exp. Med. 2005 202: 1156. [Full Text] [PDF]

This article has been cited by other articles:

• Irie, N., Takada, Y., Watanabe, Y., Matsuzaki, Y., Naruse, C., Asano, M., Iwakura, Y., Suda, T., Matsuo, K. (2009). Bidirectional Signaling through EphrinA2-EphA2 Enhances Osteoclastogenesis and Suppresses Osteoblastogenesis. J. Biol. Chem. 284: 14637-14644 [Abstract] [Full Text]  
• Sugatani, T., Hruska, K. A. (2009). Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function. J. Biol. Chem. 284: 4667-4678 [Abstract] [Full Text]  
• Flockhart, R. J., Diffey, B. L., Farr, P. M., Lloyd, J., Reynolds, N. J. (2008). NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure. FASEB J. 22: 4218-4227 [Abstract] [Full Text]  
• Fukushima, H., Nakao, A., Okamoto, F., Shin, M., Kajiya, H., Sakano, S., Bigas, A., Jimi, E., Okabe, K. (2008). The Association of Notch2 and NF-{kappa}B Accelerates RANKL-Induced Osteoclastogenesis. Mol. Cell. Biol. 28: 6402-6412 [Abstract] [Full Text]  
• Bourajjaj, M., Armand, A.-S., da Costa Martins, P. A., Weijts, B., van der Nagel, R., Heeneman, S., Wehrens, X. H., De Windt, L. J. (2008). NFATc2 Is a Necessary Mediator of Calcineurin-dependent Cardiac Hypertrophy and Heart Failure. J. Biol. Chem. 283: 22295-22303 [Abstract] [Full Text]  
• Chang, E.-J., Ha, J., Huang, H., Kim, H. J., Woo, J. H., Lee, Y., Lee, Z. H., Kim, J. H., Kim, H.-H. (2008). The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell Sci. 121: 2555-2564 [Abstract] [Full Text]  
• Lorenzo, J., Horowitz, M., Choi, Y. (2008). Osteoimmunology: Interactions of the Bone and Immune System. Endocr. Rev. 29: 403-440 [Abstract] [Full Text]  
• Datta, H K, Ng, W F, Walker, J A, Tuck, S P, Varanasi, S S (2008). The cell biology of bone metabolism. J. Clin. Pathol. 61: 577-587 [Abstract] [Full Text]  
• Lee, S. H., Kim, T., Jeong, D., Kim, N., Choi, Y. (2008). The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation. J. Biol. Chem. 283: 11526-11534 [Abstract] [Full Text]  
• Yao, Z., Xing, L., Qin, C., Schwarz, E. M., Boyce, B. F. (2008). Osteoclast Precursor Interaction with Bone Matrix Induces Osteoclast Formation Directly by an Interleukin-1-mediated Autocrine Mechanism. J. Biol. Chem. 283: 9917-9924 [Abstract] [Full Text]  
• Fretz, J. A., Shevde, N. K., Singh, S., Darnay, B. G., Pike, J. W. (2008). Receptor Activator of Nuclear Factor-{kappa}B Ligand-Induced Nuclear Factor of Activated T Cells (C1) Autoregulates Its Own Expression in Osteoclasts and Mediates the Up-Regulation of Tartrate-Resistant Acid Phosphatase. Mol. Endocrinol. 22: 737-750 [Abstract] [Full Text]  
• Kim, K., Lee, S.-H., Ha Kim, J., Choi, Y., Kim, N. (2008). NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP). Mol. Endocrinol. 22: 176-185 [Abstract] [Full Text]  
• Gurda, G. T., Guo, L., Lee, S.-H., Molkentin, J. D., Williams, J. A. (2008). Cholecystokinin Activates Pancreatic Calcineurin-NFAT Signaling In Vitro and In Vivo. Mol. Biol. Cell 19: 198-206 [Abstract] [Full Text]  
• Habib, T., Park, H., Tsang, M., de Alboran, I. M., Nicks, A., Wilson, L., Knoepfler, P. S., Andrews, S., Rawlings, D. J., Eisenman, R. N., Iritani, B. M. (2007). Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. JCB 179: 717-731 [Abstract] [Full Text]  
• Ali, Md. M., Yoshizawa, T., Ishibashi, O., Matsuda, A., Ikegame, M., Shimomura, J., Mera, H., Nakashima, K., Kawashima, H. (2007). PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts. J. Cell Sci. 120: 2565-2573 [Abstract] [Full Text]  
• Ochi, S., Shinohara, M., Sato, K., Gober, H.-J., Koga, T., Kodama, T., Takai, T., Miyasaka, N., Takayanagi, H. (2007). Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc. Natl. Acad. Sci. USA 104: 11394-11399 [Abstract] [Full Text]  
• Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I. R., Schwarz, E. M., Takeshita, S., Wagner, E. F., Noda, M., Matsuo, K., Xing, L., Boyce, B. F. (2007). NF-{kappa}B p50 and p52 Regulate Receptor Activator of NF-{kappa}B Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1. J. Biol. Chem. 282: 18245-18253 [Abstract] [Full Text]  
• Kim, K., Kim, J. H., Lee, J., Jin, H. M., Kook, H., Kim, K. K., Lee, S. Y., Kim, N. (2007). MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259 [Abstract] [Full Text]  
• Teitelbaum, S. L. (2007). Osteoclasts: What Do They Do and How Do They Do It?. Am. J. Pathol. 170: 427-435 [Abstract] [Full Text]  
• Sun, L., Peng, Y., Zaidi, N., Zhu, L.-L., Iqbal, J., Yamoah, K., Wang, X., Liu, P., Abe, E., Moonga, B. S., Epstein, S., Zaidi, M. (2007). Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am. J. Physiol. Renal Physiol. 292: F285-F291 [Abstract] [Full Text]  
• Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., Cua, D. J., Takayanagi, H. (2006). Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. JEM 203: 2673-2682 [Abstract] [Full Text]  
• Maruyama, K., Takada, Y., Ray, N., Kishimoto, Y., Penninger, J. M., Yasuda, H., Matsuo, K. (2006). Receptor Activator of NF-{kappa}B Ligand and Osteoprotegerin Regulate Proinflammatory Cytokine Production in Mice. J. Immunol. 177: 3799-3805 [Abstract] [Full Text]  
• Takayanagi, H. (2006). Amazing Multifunctionality of Calcineurin and NFAT Signaling in Bone Homeostasis. IBMS BoneKEy 3: 28-31 [Full Text]  
• Ikeda, F., Nishimura, R., Matsubara, T., Hata, K., Reddy, S. V., Yoneda, T. (2006). Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity. J. Immunol. 177: 2384-2390 [Abstract] [Full Text]  
• Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., Takayanagi, H. (2005). Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. JCB 171: i10-i10 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS